How many drugs treat Acute gonococcal endometritis?

Drug Landscape tracks 10 marketed treatments for Acute gonococcal endometritis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/acute-gonococcal-endometritis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Acute gonococcal endometritis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acute gonococcal endometritis (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Acute gonococcal endometritis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
ALATROFLOXACIN	ALATROFLOXACIN	Pfizer	alatrofloxacin		1997-01-01
Ceftin	CEFUROXIME AXETIL	GSK	Cephalosporin Antibacterial		1987-01-01
Rocephin	ceftriaxone	Generic (originally Roche)	Cephalosporin antibiotic (third-generation)	Alpha-synuclein, D-amino-acid oxidase, Penicillin-binding protein 1A	1984-12-21
Zinacef	CEFUROXIME	GSK	Cephalosporin Antibacterial	Carbonic anhydrase 2	1983-01-01
Minocycline Hydrochloride	MINOCYCLINE	Rempex	Tetracycline-class Drug		1971-01-01
Vibramycin	doxycycline	Generic (originally Pfizer)	Tetracycline antibiotic	72 kDa type IV collagenase, Stromelysin-1, Collagenase 3	1967-01-01
Unasyn	AMPICILLIN	Bristol-Myers Squibb	Penicillin-class Antibacterial	Transient receptor potential cation channel subfamily M member 4	1965-01-01
Benzamycin	Erythromycin Lactobionate	Pfizer	Macrolide	Potassium voltage-gated channel subfamily H member 2	1964-01-01
Demethylchlortetracycline	DEMECLOCYCLINE	Pfizer	Tetracycline-class Antimicrobial	Estrogen receptor beta	1960-01-01
E-Mycin	erythromycin	Generic (originally Abbott/Lilly)	Macrolide [EPC]	Aldehyde oxidase, Bile salt export pump, Cytochrome P450 1B1	1952-01-01

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 8 drugs in Acute gonococcal endometritis
Pfizer · 3 drugs in Acute gonococcal endometritis
GSK · 2 drugs in Acute gonococcal endometritis
Bulovka Hospital · 1 drug in Acute gonococcal endometritis
Centre Hospitalier Universitaire Vaudois · 1 drug in Acute gonococcal endometritis
Generic (originally Abbott/Lilly) · 1 drug in Acute gonococcal endometritis
Generic (originally Pfizer) · 1 drug in Acute gonococcal endometritis
Generic (originally Roche) · 1 drug in Acute gonococcal endometritis
Johnson And Johnson · 1 drug in Acute gonococcal endometritis
Rempex · 1 drug in Acute gonococcal endometritis
University of Southern California · 1 drug in Acute gonococcal endometritis
Assistance Publique - Hôpitaux de Paris · 1 drug in Acute gonococcal endometritis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Acute gonococcal endometritis:

Cite this brief

Drug Landscape (2026). Acute gonococcal endometritis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/acute-gonococcal-endometritis. Accessed 2026-06-10.

Acute gonococcal endometritis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing